Good day, and welcome to the Applied DNA Sciences First Quarter Fiscal 2025 Financial Results. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference ...

Thank you for standing by and welcome to the Fourth Quarter 2021 Codex DNA Earnings Conference Call. [Operator Instructions] I would now like to hand the conference to our Director of Investor ...

Good day, and thank you for standing by. Welcome to the second-quarter 2021 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there ...

These sequences are extremely prone to mutations and rank among the most functionally important regions in the entire human genome, together with protein-coding sequences,” said Donate Weghorn, a ...

Good afternoon, ladies and gentlemen, and welcome to the Quarter 1 2022 Codex DNA Incorporated earnings conference call. [Operator instructions] I would now likely turn a conference over to your host, ...

Todd R. Nelson, Ph.D., has served as the President, Chief Executive Officer and a member of the board of directors of Codex DNA (NASDAQ:DNAY) since July 2018. Prior to joining the company, Dr. Nelson ...

In this episode of Tiny Show and Tell Us, we hear from a listener who has Marfan syndrome and dive into the complexities of the disease. Then we talk about pathogens that eat — or infiltrate! — plant ...

Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $-0.32. Operator: Good day, and welcome to the Applied DNA Sciences First Quarter Fiscal 2025 ...

Applied DNA Sciences, Inc. (NASDAQ: APDN) Q1 2024 Earnings Call Transcript February 9, 2024 Applied DNA Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third ...

Applied DNA Sciences, Inc. (NASDAQ:APDN) Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were ...